Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan:7:39-46.
doi: 10.1016/j.eclinm.2019.01.005.

Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer

D G Evans  1   2   3 , S Thomas  4 , J Caunt  4 , A Burch  4 , A R Brentnall  5 , L Roberts  1 , A Howell  1   3 , M Wilson  6 , R Fox  4 , S Hillier  4 , D M Sibbering  7 , S Moss  5 , M G Wallis  8 , D M Eccles  9 ; FH02 study group; S Duffy  5
Affiliations

Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer

D G Evans et al. EClinicalMedicine. 2019 Jan.

Abstract

Background: Many women who are at increased risk of breast cancer due to a mother or sister diagnosed with breast cancer aged under 40 do not currently qualify for surveillance before 40 years of age. There are almost no available data to assess whether mammography screening aged 35-39 years would be effective in this group, in terms of detection of breast cancer at an early stage or cost effective.

Methods: A cohort screening study (FH02) with annual mammography was devised for women aged 35-39 to assess the sensitivity and screening performance and potential survival of women with identified tumours.

Findings: 2899 women were recruited from 12/2006-12/2015. These women underwent 12,086 annual screening mammograms and were followed for 13,365.8 years. A total of 55 breast cancers in 54 women occurred during the study period (one bilateral) with 50 cancers (49 women) (15 CIS) adherent to the screening. Eighty percent (28/35) of invasive cancers were ≤ 2 cm and 80% also lymph node negative. Invasive cancers diagnosed in FH02 were significantly smaller than the comparable (POSH-unscreened prospective) study group (45% (131/293) ≤ 2 cm in POSH vs 80% (28/35) in FH02 p < 0.0001), and were less likely to be lymph-node positive (54% (158/290, 3 unknown) in POSH vs 20% (7/35) in FH02: p = 0.0002. Projected and actual survival were also better than POSH. Overall radiation dose was not higher than in an older screened population at mean dose on study per standard sized breast of 1.5 mGy.

Interpretation: Mammography screening aged 35-39 years detects breast cancer at an early stage and is likely to be as effective in reducing mortality as in women at increased breast cancer risk aged 40-49 years.

Keywords: BRCA1; BRCA2; Breast cancer; Familial; Mammography; Young.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Breast cancer specific survival in invasive cases versus POSH Family history positive cases.
Fig. 2
Fig. 2
Mean glandular dose per image as a function of breast thickness. FH02 refers to women aged 35–39 years in the present study and BSP refers to published data for older women in the NHS Breast Screening Programme . Error bars show ± 2 standard errors.
See this image and copyright information in PMC

References

    1. Evans D.G., Thomas S., Caunt J., Roberts L., Howell A., Wilson M. Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02) Familial Cancer. 2014;13(1):13–21. - PubMed
    1. Mackay J., Rogers C., Fielder H. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J Epidemiol Biostat. 2001;6:365–369. - PubMed
    1. FH01 management committee, steering committee and collaborators The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J Med Screen. 2006;13:177–182. - PubMed
    1. FH01 collaborative teams Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol. 2010;11:1127–1134. - PubMed
    1. McIntosh A., Shaw C., Evans G. Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer, London: National Collaborating Centre for Primary Care/University of Sheffield. NICE guideline CG164. www.nice.org.uk [2013 updated 2017]